Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrice Dubreuil

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Molecular Immunology|April 29, 2014
Molecular basis of mast cell diseaseErinn Soucie, Fabienne Brenet, Patrice Dubreuil
Blood|June 28, 2007
The tyrosine kinase FES is an essential effector of KITD816V proliferation signalEdwige Voisset, Sophie Lopez, Patrice Dubreuil, et al.
Plos One|October 12, 2013
Nectin-3 (CD113) interacts with Nectin-2 (CD112) to promote lymphocyte transendothelial migrationElisabeth Devilard, Luc Xerri, Patrice Dubreuil, et al.
Plos One|November 13, 2015
Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell TumorsEleonora Zorzan, Katia Hanssens, Mery Giantin, et al.
The Journal of Biological Chemistry|January 7, 2004
Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signalingJulie Bayle, Sébastien Letard, Ronald Frank, et al.
FEBS Letters|April 29, 2006
The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteinsJulie Bayle, Sophie Lopez, Kazuhiro Iwaï, et al.
Pharmacology & Therapeutics|December 18, 2018
KIT as a therapeutic target for non-oncological diseasesAsuncion Martinez-Anton, Delphine Gras, Arnaud Bourdin, et al.
FEBS Letters|April 7, 2005
PICK-1: a scaffold protein that interacts with Nectins and JAMs at cell junctionsNicolas Reymond, Sarah Garrido-Urbani, Jean-Paul Borg, et al.
F1000Research|December 12, 2019
Recent advances in the understanding and therapeutic management of mastocytosisJulien Rossignol, Laura Polivka, Leila Maouche-Chrétien, et al.
Cancer Cell|December 13, 2005
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in miceOlivier Kosmider, Nicole Denis, Catherine Lacout, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Molecular Immunology|April 29, 2014
Molecular basis of mast cell diseaseErinn Soucie, Fabienne Brenet, Patrice Dubreuil
Blood|June 28, 2007
The tyrosine kinase FES is an essential effector of KITD816V proliferation signalEdwige Voisset, Sophie Lopez, Patrice Dubreuil, et al.
Plos One|October 12, 2013
Nectin-3 (CD113) interacts with Nectin-2 (CD112) to promote lymphocyte transendothelial migrationElisabeth Devilard, Luc Xerri, Patrice Dubreuil, et al.
Plos One|November 13, 2015
Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell TumorsEleonora Zorzan, Katia Hanssens, Mery Giantin, et al.
The Journal of Biological Chemistry|January 7, 2004
Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signalingJulie Bayle, Sébastien Letard, Ronald Frank, et al.
FEBS Letters|April 29, 2006
The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteinsJulie Bayle, Sophie Lopez, Kazuhiro Iwaï, et al.
Pharmacology & Therapeutics|December 18, 2018
KIT as a therapeutic target for non-oncological diseasesAsuncion Martinez-Anton, Delphine Gras, Arnaud Bourdin, et al.
FEBS Letters|April 7, 2005
PICK-1: a scaffold protein that interacts with Nectins and JAMs at cell junctionsNicolas Reymond, Sarah Garrido-Urbani, Jean-Paul Borg, et al.
F1000Research|December 12, 2019
Recent advances in the understanding and therapeutic management of mastocytosisJulien Rossignol, Laura Polivka, Leila Maouche-Chrétien, et al.
Cancer Cell|December 13, 2005
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in miceOlivier Kosmider, Nicole Denis, Catherine Lacout, et al.
Pageof 10